Back to Arizona

HB2048 • 2026

orders of protection; process servers

HB2048 - (NOW: AHCCCS; non-opioid prescription drugs; controls)

Children Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Selina Bliss
Last action
2026-06-11
Official status
House passed
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

orders of protection; process servers

HB2048 - 572R - Senate Fact Sheet Assigned to HHS�������������������������������������������������������������������������������������������������������������� AS PASSED BY COW ARIZONA STATE SENATE Fifty-Seventh Legislature, Second Regular Session AMENDED FACT SHEET FOR H.B.

What This Bill Does

  • HB2048 - 572R - Senate Fact Sheet Assigned to HHS�������������������������������������������������������������������������������������������������������������� AS PASSED BY COW ARIZONA STATE SENATE Fifty-Seventh Legislature, Second Regular Session AMENDED FACT SHEET FOR H.B.
  • 2048 orders of protection; process servers ( NOW: AHCCCS; non-opioid prescription drugs; controls ) Purpose Prohibits the Arizona Health Care Cost Containment System (AHCCCS) from imposing more restrictive utilization controls on prescription non-opioid drugs used to treat moderate to severe pain than on prescription opioid or narcotic drugs.
  • Background AHCCCS serves as Arizona's Medicaid agency, which offers Arizona residents access to healthcare programs.
  • AHCCCS contracts with health plans to deliver medically necessary services to enrolled members, including low-income adults, children, pregnant women and individuals with disabilities ( A.R.S.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

Plain English: Fifty-seventh Legislature Health and Human Services Second Regular Session H.B.

  • Fifty-seventh Legislature Health and Human Services Second Regular Session H.B.
  • 2048 COMMITTEE ON HEALTH AND HUMAN SERVICES SENATE AMENDMENTS TO H.B.
  • 2048 (Reference to House engrossed bill) Strike everything after the enacting clause and insert: 1 "Section 1.
  • Arizona health care cost containment system 2 administration; prescription drugs; pain 3 treatment; utilization controls; delayed repeal 4 A.
  • This amendment summary is using official source text because generated interpretation was skipped for this run.

Plain English: Fifty-seventh Legislature Health and Human Services Second Regular Session H.B.

  • Fifty-seventh Legislature Health and Human Services Second Regular Session H.B.
  • 2048 PROPOSED SENATE AMENDMENTS TO H.B.
  • 2048 (Reference to House engrossed bill) Strike everything after the enacting clause and insert: 1 "Section 1.
  • Arizona health care cost containment system 2 administration; prescription drugs; pain 3 treatment; utilization controls; delayed repeal 4 A.
  • This amendment summary is using official source text because generated interpretation was skipped for this run.

Bill History

  1. 2026-06-11 House

    House passed

  2. 2026-06-10 House

    House minority caucus

  3. 2026-06-09 House

    Transmitted to House

  4. 2026-06-09 Senate

    Senate third read passed

  5. 2026-06-01 Senate

    Senate committee of the whole

  6. 2026-04-21 Senate

    Senate minority caucus

  7. 2026-04-21 Senate

    Senate majority caucus

  8. 2026-03-04 Senate

    Senate second read

  9. 2026-03-03 Senate

    Senate Rules: PFC

  10. 2026-03-03 Senate

    Senate Health and Human Services: DPA/SE

  11. 2026-03-03 Senate

    Senate Public Safety: W/D

  12. 2026-03-03 Senate

    Senate first read

  13. 2026-02-26 Senate

    Transmitted to Senate

  14. 2026-02-26 House

    House third read passed

  15. 2026-02-25 House

    House committee of the whole

  16. 2026-01-27 House

    House minority caucus

  17. 2026-01-27 House

    House majority caucus

  18. 2026-01-26 House

    House consent calendar

  19. 2026-01-13 House

    House second read

  20. 2026-01-12 House

    House Rules: C&P

  21. 2026-01-12 House

    House Judiciary: DP

  22. 2026-01-12 House

    House first read

Official Summary Text

HB2048 - 572R - Senate Fact Sheet

Assigned to
HHS�������������������������������������������������������������������������������������������������������������� AS
PASSED BY COW

ARIZONA STATE SENATE

Fifty-Seventh
Legislature, Second Regular Session

AMENDED

FACT SHEET FOR
H.B. 2048

orders
of protection; process servers

(
NOW:
AHCCCS; non-opioid prescription drugs; controls
)

Purpose

Prohibits the Arizona Health Care Cost Containment System (AHCCCS) from
imposing more restrictive utilization controls on prescription non-opioid drugs
used to treat moderate to severe pain than on prescription opioid or narcotic
drugs.

Background

AHCCCS serves as Arizona's Medicaid agency, which offers Arizona
residents access to healthcare programs. AHCCCS contracts with health plans to
deliver medically necessary services to enrolled members, including low-income
adults, children, pregnant women and individuals with disabilities (
A.R.S. � 36-2903
).

The AHCCCS Pharmacy & Therapeutics Committee (Committee) serves as an
advisory body to the AHCCCS administration and is responsible for evaluating
scientific evidence of the relative safety, efficacy, effectiveness and
clinical appropriateness of prescription drugs. The Committee makes
recommendations to the AHCCCS administration on the development and maintenance
of a statewide drug list and prior authorization criteria as appropriate. The
Committee may also evaluate individual drugs and therapeutic classes of drugs (
AHCCCS
).

If prohibiting AHCCCS from imposing more restrictive utilization
controls on prescription non-opioid drugs than on prescription opioid or
narcotic drugs results in increased utilization or costs, there may be a fiscal
impact to the state General Fund.

Provisions

1.

Prohibits
AHCCCS from establishing utilization controls, including prior authorization or
step therapy requirements, on any clinically appropriate prescription
non-opioid drug approved by the U.S. Food and Drug Administration to treat
chronic or acute moderate to severe pain that are more restrictive or extensive
than the least restrictive or extensive utilization controls applicable to any
clinically appropriate prescription opioid or narcotic drug.

2.

Repeals
the prohibition on September 1, 2028.

3.

Becomes
effective on the general effective date.

Amendments
Adopted by Committee

�

Adopted the strike-everything amendment.

Senate Action

PS������������������� 3/17/26����� W/D

HHS��������������� 3/18/26����� DPA/SE���
4-3-0

Prepared by Senate Research

June 1, 2026

MM/hk

Current Bill Text

Read the full stored bill text
HB2048 - 572R - S Ver

Senate Engrossed
House Bill

orders
of protection; process servers

(now: AHCCCS;
non-opioid prescription drugs; controls)

State of Arizona

House of Representatives

Fifty-seventh Legislature

Second Regular Session

2026

HOUSE BILL 2048

AN
ACT

Relating to the Arizona health care cost
containment system prescription drug coverage.

(TEXT OF BILL BEGINS ON NEXT PAGE)

Be it enacted by the Legislature of the State of Arizona:

Section 1.
Arizona health care cost containment system
administration; prescription drugs; pain treatment; utilization controls;
delayed repeal

A. The Arizona health care
cost containment system administration may not establish more restrictive or
extensive utilization controls, including more restrictive or extensive prior
authorization or step therapy requirements, for any clinically appropriate
prescription drug that is not an opioid and that is approved by the United
States food and drug administration to treat chronic or acute moderate to
severe pain that are more restrictive or extensive than the least restrictive
or extensive utilization controls applicable to any clinically appropriate
prescription drug that is an opioid or narcotic.

B. This section is repealed
from and after August 31, 2028.